<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Kazan medical journal</journal-id><journal-title-group><journal-title xml:lang="en">Kazan medical journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Казанский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0368-4814</issn><issn publication-format="electronic">2587-9359</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">100842</article-id><article-id pub-id-type="doi">10.17816/kazmj100842</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Theoretical and clinical medicine</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Теоретическая и клиническая медицина</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Influence of dimephosphone on myelotoxic side effect of cytostatic therapy of malignant neoplasms</article-title><trans-title-group xml:lang="ru"><trans-title>Влияние димефосфона на миэлотоксический побочный эффект цитостатической терапии злокачественных новообразований</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mokrinskaya</surname><given-names>I. S.</given-names></name><name xml:lang="ru"><surname>Мокринская</surname><given-names>И. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Pharmacology, Course of Oncology</p></bio><bio xml:lang="ru"><p>Кафедра фармакологии, курс онкологии</p></bio><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Studentsova</surname><given-names>I. A.</given-names></name><name xml:lang="ru"><surname>Студенцова</surname><given-names>И. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Pharmacology, Course of Oncology</p></bio><bio xml:lang="ru"><p>Кафедра фармакологии, курс онкологии</p></bio><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khafizyanova</surname><given-names>R. H.</given-names></name><name xml:lang="ru"><surname>Хафизьянова</surname><given-names>Р. Х.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Pharmacology, Course of Oncology</p></bio><bio xml:lang="ru"><p>Кафедра фармакологии, курс онкологии</p></bio><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Novozhilova</surname><given-names>N. N.</given-names></name><name xml:lang="ru"><surname>Новожилова</surname><given-names>Н. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Pharmacology, Course of Oncology</p></bio><bio xml:lang="ru"><p>Кафедра фармакологии, курс онкологии</p></bio><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zalyalyutdinova</surname><given-names>L. N.</given-names></name><name xml:lang="ru"><surname>Залялютдинова</surname><given-names>Л. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Pharmacology, Course of Oncology</p></bio><bio xml:lang="ru"><p>Кафедра фармакологии, курс онкологии</p></bio><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Сафина</surname><given-names>S. Z.</given-names></name><name xml:lang="ru"><surname>Сафина</surname><given-names>С. З.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Pharmacology, Course of Oncology</p></bio><bio xml:lang="ru"><p>Кафедра фармакологии, курс онкологии</p></bio><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Akhmetzyanov</surname><given-names>F. Sh.</given-names></name><name xml:lang="ru"><surname>Ахметзянов</surname><given-names>Ф. Ш.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Pharmacology, Course of Oncology</p></bio><bio xml:lang="ru"><p>Кафедра фармакологии, курс онкологии</p></bio><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kazan Medical University</institution></aff><aff><institution xml:lang="ru">Казанский медицинский университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="1995-05-15" publication-format="electronic"><day>15</day><month>05</month><year>1995</year></pub-date><volume>76</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>218</fpage><lpage>219</lpage><history><date date-type="received" iso-8601-date="2022-02-16"><day>16</day><month>02</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-02-16"><day>16</day><month>02</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 1995, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 1995, Эко-Вектор</copyright-statement><copyright-year>1995</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://kazanmedjournal.ru/kazanmedj/article/view/100842">https://kazanmedjournal.ru/kazanmedj/article/view/100842</self-uri><abstract xml:lang="en"><p>This paper presents the results of studying the effect of dimephosphone in combination with cyclophosphamide on the hematological parameters of tumor-carrying animals, as well as in combination with polychemotherapy in patients with malignant neoplasms. The experimental part of the work was carried out on 50 rats with transplanted ascitic ovarian tumor. One day after the transplantation of the tumor, the animals were divided into groups of 10 animals each. The rats of the control group were injected intraperitoneally with distilled water, the 1st experimental group received dimephosphone in the stomach at a dose of 200 mg/kg, the 2nd group received intraperitoneal cyclophosphamide at a dose of 10 mg/kg, the 3rd group received cyclophosphamide and dimephosphone at the same doses. The drugs were administered daily for 9 days. Intact animals were taken for comparison of indicators.</p></abstract><trans-abstract xml:lang="ru"><p>В настоящей работе приведены результаты изучения влияния димефосфона в сочетании с циклофосфаном на гематологические показатели животных-опухоленосителей, а также в сочетании с полихимиотерапией у больных со злокачественными новообразованиями. Экспериментальная часть работы выполнена на 50 крысах с перевитой асцитной опухолью яичника. Через сутки после перевивки опухоли животные были разделены на группы по 10 особей в каждой. Крысам контрольной группы вводили внутрибрюшинно дистиллированную воду, 1-й опытной — димефосфон в желудок в дозе 200 мг/кг, 2-й — циклофосфан внутрибрюшинно в дозе 10 мг/кг, 3-й — циклофосфан и димефосфон в тех же дозах. Препараты вводили ежедневно в течение 9 дней. Интактные животные взяты для сопоставления показателей.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Kazan Medical archive</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Казанский медицинский архив</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list/></back></article>
